Suppr超能文献

G蛋白偶联受体信号转导调控:G蛋白偶联受体激酶和抑制蛋白的作用

GPCR Signaling Regulation: The Role of GRKs and Arrestins.

作者信息

Gurevich Vsevolod V, Gurevich Eugenia V

机构信息

Department of Pharmacology, Vanderbilt University, Nashville, TN, United States.

出版信息

Front Pharmacol. 2019 Feb 19;10:125. doi: 10.3389/fphar.2019.00125. eCollection 2019.

Abstract

Every animal species expresses hundreds of different G protein-coupled receptors (GPCRs) that respond to a wide variety of external stimuli. GPCRs-driven signaling pathways are involved in pretty much every physiological function and in many pathologies. Therefore, GPCRs are targeted by about a third of clinically used drugs. The signaling of most GPCRs via G proteins is terminated by the phosphorylation of active receptor by specific kinases (GPCR kinases, or GRKs) and subsequent binding of arrestin proteins, that selectively recognize active phosphorylated receptors. In addition, GRKs and arrestins play a role in multiple signaling pathways in the cell, both GPCR-initiated and receptor-independent. Here we focus on the mechanisms of GRK- and arrestin-mediated regulation of GPCR signaling, which includes homologous desensitization and redirection of signaling to additional pathways by bound arrestins.

摘要

每个动物物种都表达数百种不同的G蛋白偶联受体(GPCR),这些受体对各种各样的外部刺激作出反应。GPCR驱动的信号通路几乎涉及每一种生理功能以及许多病理过程。因此,约三分之一的临床用药都以GPCR为靶点。大多数GPCR通过G蛋白进行的信号传导通过特定激酶(GPCR激酶,即GRK)对活性受体的磷酸化作用以及随后抑制蛋白的结合而终止,抑制蛋白可选择性识别活性磷酸化受体。此外,GRK和抑制蛋白在细胞内的多种信号通路中发挥作用,包括GPCR启动的信号通路和不依赖受体的信号通路。在这里,我们重点关注GRK和抑制蛋白介导的GPCR信号调节机制,其中包括同源脱敏以及结合的抑制蛋白将信号重定向至其他通路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8311/6389790/0fdb81712f90/fphar-10-00125-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验